BUY Glenmark Pharmaceuticals — Rachit Khandelwal
Glenmark Pharmaceuticals share price target & all analyst calls
byRachit KhandelwalHorizon: NA (inferred Intraday)8 Sept 2026, 12:29 pm ISTvia Business Today
Entry₹2,489.9Inferred
Stop loss₹2,410-3.21% risk
At expiry₹2,4798 Sept 2026, 3:05 pm
Expired-0.44%
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 supporting0 opposing
Supports the BUY call (1)
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Glenmark Pharmaceuticals
- BUY — Prakash Gaba21 Oct 2026 · Same day · target ₹2,300 · SL hit
- BUY — Somil Mehta, Sharekhan19 Oct 2026 · ~2 weeks · target ₹2,400 · SL hit
- BUY — Osho Krishan, Angel One13 Oct 2026 · ~2 weeks · target ₹2,400 · Active
- BUY — Manas Jaiswal9 Oct 2026 · ~2 weeks · target ₹2,375 · SL hit
- BUY — Prakash Gaba9 Oct 2026 · ~2 weeks · target ₹2,350 · SL hit
More from Rachit Khandelwal
- BUY Cummins India21 Oct 2026 · ~2 weeks · target ₹4,940 · Active
- BUY Cholamandalam Financial Holdings21 Oct 2026 · ~2 weeks · target ₹1,580 · Active
- BUY Moschip Technologies21 Oct 2026 · ~2 weeks · target ₹204 · Active
- BUY Usha Martin21 Oct 2026 · ~2 weeks · target ₹491 · SL hit
- BUY NIBE14 Oct 2026 · ~2 weeks · target ₹1,470 · SL hit